Factors Affecting Prevalence of Urinary Tract Infection in Neonates with Unexplained Hyperbilirubinemia: A Systematic

Fahimeh Bagheri Amiri1, Sanaz Tavasoli1, Nasrin Borumandnia1

  • 1Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Insights

Urinary tract infection (UTI) affects 6.81% of Iranian neonates with unexplained hyperbilirubinemia. Male gender and low birth weight significantly increase UTI risk in this vulnerable population.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Urinary tract infection (UTI) prevalence and risk factors in neonates with unexplained hyperbilirubinemia require further investigation.
  • UTI prevalence varies geographically, necessitating region-specific data.

Purpose of the Study:

  • To determine the pooled prevalence of UTI in Iranian neonates presenting with unexplained hyperbilirubinemia.
  • To identify risk factors associated with UTI in this specific neonatal population.

Main Methods:

  • A meta-analysis was conducted using data from 2000-2018.
  • International (Web of Science, PubMed, Scopus, Google Scholar) and national (Science Information Database, Magiran) databases were searched.
  • Keywords included "Urinary Tract Infections OR UTI", "urine OR culture OR microbio", "jaundice OR icter OR hyperbili", and "Iran".

Main Results:

  • A total of 4210 neonates from 17 studies were analyzed.
  • The pooled prevalence of UTI was 6.81% (95% CI: 4.86-8.77).
  • Higher UTI prevalence was observed in neonates with prolonged jaundice, low birth weight, and exclusive breastfeeding. Male gender and low birth weight approximately doubled the risk of UTI.

Conclusions:

  • A significant prevalence of UTI exists in neonates with unexplained hyperbilirubinemia.
  • Given the identified risk factors, screening for UTI is crucial in the workup of these neonates.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
78
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
137